Nicolas Sluis‐Cremer

4.0k citations

111 papers · 3.1k indexed · h-index 34

Virology top 0.2%
- HIV Research and Treatment 89
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 83
- HIV/AIDS Research and Interventions 37
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
Endocrinology top 5%
Molecular Biology top 10%
- DNA and Nucleic Acid Chemistry 14
- Biochemical and Molecular Research 12
Immunology
- Immune Cell Function and Interaction 10
Epidemiology
- Cytomegalovirus and herpesvirus research 8

Co-authors: Gilda Tachedjian John W. Mellors Michael A. Parniak Dominique Arion Jessica Radzio Kelly Huber Heini W. Dirr Yohei Doi
Cited by: Virology Infectious Diseases Molecular Medicine
Journals: Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)Journal of Biological Chemistry (5 papers)
Partner nations: United States Australia Canada

In The Last Decade

Nicolas Sluis‐Cremer

107 papers receiving 3.1k citations

Peers

Countries citing papers authored by Nicolas Sluis‐Cremer

Since Specialization

Citations

This map shows the geographic impact of Nicolas Sluis‐Cremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Sluis‐Cremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Sluis‐Cremer more than expected).

Fields of papers citing papers by Nicolas Sluis‐Cremer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Sluis‐Cremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Sluis‐Cremer. The network helps show where Nicolas Sluis‐Cremer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nicolas Sluis‐Cremer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolas Sluis‐Cremer Line = papers co-authored together Nicolas Sluis‐Cremer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence AIDS ·Yijia Li,Zoamy N. Soto-Ramirez,Jennifer Roscher,Tom Medvec,Mounia Alaoui-El-Azher,Paolo Piazza,Yue Chen,Nicolas Sluis‐Cremer,Charles R. Rinaldo,Bernard Macatangay	2025	2
2	Structural basis of deoxynucleotide addition by HIV-1 RT during reverse transcription Nature Communications ·Sandra Vergara,Xiaohong Zhou,Ulises Santiago,Mounia Alaoui-El-Azher,James F. Conway,Nicolas Sluis‐Cremer,Guillermo Calero	2024	2
3	Mechanism by Which PF-3758309, a Pan Isoform Inhibitor of p21-Activated Kinases, Blocks Reactivation of HIV-1 Latency Biomolecules ·Benni Vargas,James Boslett,Nathan A. Yates,Nicolas Sluis‐Cremer	2023	1
4	Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach Molecules ·Mahta Mansouri,Shawn Rumrill,Shane Dawson,Adam Johnson,Jo‐Anne Pinson,Menachem J. Gunzburg,Catherine F. Latham,Νicholas Barlow,George W. Mbogo,Paula Ellenberg,Stephen J. Headey,Nicolas Sluis‐Cremer,David Tyssen,Joseph D. Bauman,Francesc X. Ruiz,Eddy Arnold,David K. Chalmers,Gilda Tachedjian	2023	4
5	RING Program: The CFAR Diversity, Equity, and Inclusion Pathway Initiative JAIDS Journal of Acquired Immune Deficiency Syndromes ·Nicolas Sluis‐Cremer,Edwin E. Traverso Avilés,Orestes Quesada González,Carlos Ríos‐Velázquez,Patricia Ortiz‐Bermúdez,Robert Ross,Alan D. Levine	2023	1
6	The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification RSC Medicinal Chemistry ·Christy El-Khoury,Elissar Mansour,Yori Yuliandra,Felcia Lai,Bryson A. Hawkins,Jonathan J. Du,Eric J. Sundberg,Nicolas Sluis‐Cremer,David E. Hibbs,Paul W. Groundwater	2022	12
7	B Lymphocytes, but Not Dendritic Cells, Efficiently HIV-1 Trans Infect Naive CD4 ⁺ T Cells: Implications for the Viral Reservoir mBio ·Abigail Gerberick,Diana C. DeLucia,Paolo Piazza,Mounia Alaoui-El-Azher,Charles R. Rinaldo,Nicolas Sluis‐Cremer,Giovanna Rappocciolo	2021	6
8	Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1 EBioMedicine ·Jan Kristoff,Mariana L. Palma,Tatiana M. García-Bates,Chengli Shen,Nicolas Sluis‐Cremer,Phalguni Gupta,Charles R. Rinaldo,Robbie B. Mailliard	2019	18
9	High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium Emerging infectious diseases ·Yan Guo,Adam D. Tomich,Christi L. McElheny,Vaughn S. Cooper,Amelia Tait‐Kamradt,Minggui Wang,Fupin Hu,Louis B. Rice,Nicolas Sluis‐Cremer,Yohei Doi	2017	23
10	Glutathione-S-transferase FosA6 ofKlebsiella pneumoniaeorigin conferring fosfomycin resistance in ESBL-producingEscherichia coli Journal of Antimicrobial Chemotherapy ·Qinglan Guo,Adam D. Tomich,Christi L. McElheny,Vaughn S. Cooper,Nicole Stoesser,Minggui Wang,Nicolas Sluis‐Cremer,Yohei Doi	2016	50
11	Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells Current Topics in Medicinal Chemistry ·Nicolas Sluis‐Cremer	2015	2
12	Failure of Initial Therapy With Two Nucleosides and Efavirenz Is Not Associated With Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jessica H. Brehm,Christina M. Lalama,Michael D. Hughes,Richard Haubrich,Sharon A. Riddler,Nicolas Sluis‐Cremer,John W. Mellors	2011	3
13	Synthesis and evaluation of 3′-azido-2′,3′-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus Bioorganic & Medicinal Chemistry Letters ·Hongwang Zhang,Steven J. Coats,Lavanya Bondada,Franck Amblard,Mervi Detorio,Ghazia Asif,Emilie Fromentin,Sarah Solomon,Aleksandr Obikhod,Tony Whitaker,Nicolas Sluis‐Cremer,John W. Mellors,Raymond F. Schinazi	2009	11
14	Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency AIDS ·P. Richard Harrigan,Chih‐Wei Sheen,Vikram S. Gill,Brian Wynhoven,Erin Hudson,Viviane D. Lima,Pierre Lecocq,Rosalia Aguirre,Art F. Y. Poon,Nicolas Sluis‐Cremer	2008	13
15	N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance PLoS Medicine ·Soo-Huey Yap,Chih‐Wei Sheen,Jonathan M. Fahey,Mark Zanin,David Tyssen,Viviane D. Lima,Brian Wynhoven,Michael J. Kuiper,Nicolas Sluis‐Cremer,P. Richard Harrigan,Gilda Tachedjian	2007	138
16	Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol PLoS Pathogens ·Anna Figueiredo,Katie L. Moore,Johnson Mak,Nicolas Sluis‐Cremer,Marie‐Pierre de Béthune,Gilda Tachedjian	2006	85
17	Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target Current Pharmaceutical Design ·Seema Srivastava,Nicolas Sluis‐Cremer,Gilda Tachedjian	2006	24
18	Stereo‐selectivity of HIV‐1 reverse transcriptase toward isomers of thymidine‐5′‐O‐1‐thiotriphosphate Protein Science ·Jessica Radzio,Nicolas Sluis‐Cremer	2005	7
19	Conformational Changes in HIV-1 Reverse Transcriptase Induced by Nonnucleoside Reverse Transcriptase Inhibitor Binding Current HIV Research ·Nicolas Sluis‐Cremer,Nuri A. Temiz,İvet Bahar	2004	111
20	Conformational stability of Cys⁴⁵‐alkylated and hydrogen peroxide‐oxidised glutathione S‐transferase FEBS Letters ·Nicolas Sluis‐Cremer,Heini W. Dirr	1995	9

About Nicolas Sluis‐Cremer

Nicolas Sluis‐Cremer is a scholar working on Virology, Infectious Diseases and Molecular Medicine, having authored 111 papers that have together received 3.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (89 papers), HIV/AIDS drug development and treatment (83 papers), HIV/AIDS Research and Interventions (37 papers), DNA and Nucleic Acid Chemistry (14 papers), Biochemical and Molecular Research (12 papers), Immune Cell Function and Interaction (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Cytomegalovirus and herpesvirus research (8 papers). The work is most often cited by research in Virology (2.0k citations), Infectious Diseases (2.0k citations) and Molecular Medicine (330 citations). Nicolas Sluis‐Cremer has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Gilda Tachedjian, John W. Mellors, Michael A. Parniak, Dominique Arion, Jessica Radzio, Kelly Huber, Heini W. Dirr, Yohei Doi, Jennifer M. Zerbato and Geneviève Doyon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact